Cataract Surgery on Advanced Age Related Macular Degeneration Patients

Not Applicable

Withdrawn

• Conditions: Cataract; Macular Degeneration Advanced

• Registration Number: NCT04045704
• Lead Sponsor: University of British Columbia

Brief Summary

The degree at which cataract surgery improves visual function in patients with advanced age-related macular degeneration (Advanced AMD) has been an on-going topic of discussion. Our objective in this study is to determine if patients with Advanced AMD and concurrent cataracts will experience greater improvement in their quality of life from having cataract surgery on one or both eyes. The findings from this project will provide evidence for clinical decision making on whether performing bilateral cataract surgery on Advanced AMD patients is cost-effective and worth the second surgical intervention.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design

Study Timeline

• Study First Submitted: 2019-07-17
• Study First Submitted QC: 2019-08-02
• Study First Posted: 2019-08-05
• Study Start: 2019-10
• Primary Completion: 2019-12
• Study Completion: 2019-12
• Status Verified: 2021-09
• Last Update Submitted: 2021-09-27
• Last Update Posted: 2021-10-04

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Patients above the age of fifty with both Advanced AMD and Cataracts bilaterally from the Okanagan Valley will be selected for this study.

Patients who chose to have bilateral cataract surgery, were able to understand the research parameters, and had no other severe eye disease that may distort the studies results.

Patients will be selected for the study according to the National Eye Institute definition of Advanced AMD.

"Advanced AMD (AREDS category 4) is characterized by one or more of the following (in the absence of other causes) in one eye:

Geographic atrophy of the RPE involving the foveal center.

Neovascular maculopathy that includes the following:

• Choroidal neovascularization (CNV) defined as pathologic angiogenesis originating from the choroidal vasculature that extends through a defect in Bruch's membrane
• Serous and/or hemorrhagic detachment of the neurosensory retina or RPE
• Retinal hard exudates (a secondary phenomenon resulting from chronic intravascular leakage)
• Subretinal and sub-RPE fibrovascular proliferation
• Disciform scar (subretinal fibrosis)"

Read More

Exclusion Criteria

• Severe intraoperative or postoperative complications such as retinal detachments, and capsule ruptures
• Inability to complete the required testing (auto-refractive and visual acuity)
• Inability to attend appointments
• Inability to complete the questionnaire with Co-I assistance
• Severe eye disease that may distort the studies results such as but not limited to Epithelial Basement Membrane Dystrophy (EBMD) and retinal detachments.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Life style Questionnaire to determine change in visual function.	Through study completion, an average of 1 year	Our primary outcome will be a life style questionnaire (qualitative) to determine the change in visual function from baseline to after surgery.; This questionnaire includes 25 close-ended questions that are graded on a 5 point grading scale from 1 (great difficulty due to vision) and 5 (no problem due to vision). The questions can also be graded as not applicable to an individuals life, or 0 being something there are no longer possible to do, due to vision.; The 25 close-ended questions are divided into 4 sub-scales: 1. Distance Vision, Mobility, and Lighting (Q: 1-12); 2. Adjustment (Q:13-16); 3. Reading and Fine Work (Q: 17-21); 4. Activities of Daily Living (Q: 22-25); A total score can range from a 125 indicating best visual function to 0 indicating complete loss of visual function.

Secondary Outcome Measures

Name	Time	Method
Snellens Chart to determine change in visual acuity	Through study completion, an average of 1 year	Quantitative measure of a patients visual acuity. Change from baseline visual acuity to after surgery on both eyes.
Auto Refractive to determine change in visual acuity	Through study completion, an average of 1 year	An auto-refractor is a computerized machine to measure patients visual acuity. Change from baseline visual acuity to after surgery on both eyes.